300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Isle of Man
Haiti
Iran
Madagascar
Pakistan
Lesotho
Romania
Poland
Oman
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Marshall Islands
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Alto Partners SGR, VC Fund

Alto Partners SGR

VC Fund

Milano, Italy

Alto Partners SGR is a VC fund in Milano focused on Manufacturing and Health Care. Alto Part­ners SGR mana­ges inde­pen­dent pri­vate equity funds dedi­ca­ted to the Ita­lian mid-​market.Alto Part­ners SGR pur­sues an invest­ment stra­tegy orien­ted to gro­wing and cash-​generative com­pa­nies based in Italy. The Fund pre­do­mi­nan­tly tar­gets buy­out tran­sac­tions, howe­ver also selec­ted mino­rity invest­ments arecon­si­de­red in com­pa­nies with strong share­hol­der pro­tec­tions and pre-​determined exit rou­tes.The Team com­bi­nes more than 125 years finan­cial expe­rience. In par­ti­cu­lar, the part­ners each have more than 20 years of pro­fes­sio­nal expe­rience in the Ita­lian and Inter­na­tio­nal finan­cial community.Alto Part­ners SGR assists the port­fo­lio com­pa­nies on a large num­ber of stra­te­gic, ope­ra­tio­nal and finan­cial areas, also thanks to the con­tri­bu­tion of qua­li­fied senior con­sul­tants with spe­ci­fic indu­stry knowledge.

Total investments:
13
Last investment:
Lead investor:
23%
Fund size:
$297M
Last fund:

Last updated:

Industries Alto Partners SGR invests in

ManufacturingHealth CarePharmaceuticalSnack FoodConsumer Goods

Stages Alto Partners SGR invests in

Private EquitySeries AFunding Round

Countries Alto Partners SGR invests in

ItalyIndonesiaUnited States

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Manufacturing 7 (54%)
  • Health Care 3 (23%)
  • Pharmaceutical 3 (23%)
  • Snack Food 2 (15%)
  • Consumer Goods 2 (15%)
See all 32 industries →

Stage

  • Private Equity 10 (77%)
  • Series A 1 (8%)
  • Funding Round 1 (8%)

Country

  • Italy 10 (77%)
  • Indonesia 1 (8%)
  • United States 1 (8%)

Team

NameTitleInvestmentsLinksEmail
Mario Visioni Partner
Partner Total investments: 0 Find email
Raffaele de Courten
Raffaele de Courten Founding Partner
Founding Partner Total investments: 0 Find email
Stefano Scarpis Founding Partner
Founding Partner Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
C.E.I. High Fidelity Spare Parts C.E.I. High Fidelity Spare Parts
CEI is a manufacturer and designer of spare parts for industrial vehicles. The initial product range consisting exclusively of gears for gearboxes and differentials has been widened through the years by introducing spare parts for steering and braking system, suspensions, and engine. Private Equity / Jun 01, 2022
Mipharm SPA Mipharm SPA
Mipharm was founded in January 1998 by Mr. Giuseppe G. Miglio, who can show more than 40 years of experience in the pharmaceutical world and in Sandoz Holding, where he covered many and growing positions. In 1986 he was appointed to President and Managing Director of Sandoz Prodotti Farmaceutici SpA ; in 1990 he was appointed President and ManagingDirector of Sandoz Holding Italia Spa. In 1996, he managed first the merger between Sandoz and Ciba Geigy and then he was appointed President of Novartis Italy, until he decided to found Mipharm, a new company that in few years has become an important player in pharmaceutical market both in Italy and in Europe. Mipharm acquired from Novartis the production site (former Sandoz facility) based in Milan: starting from its production capacity, many third party production agreements have been signed. Up to 2009, Mipharm developed an integrated business model based on a modern and efficient production site and on a Business Unit Promotion focused on sales & marketing of new and innovative products. Private Equity / Mar 01, 2022
Diatech Pharmacogenetics Diatech Pharmacogenetics
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the years and now owns more than 70% of the Italian molecular diagnostic market and it is rapidly growingworldwide; to date, more than 20.000 diagnostic tests have been performed using its solutions and every year Diatech Pharmacogenetics reinvests 20% of it revenues in R&D.Diatech Pharmacogenetics is able to take pharmacogenetics tests from idea to market on a variety of platforms, from real-time PCR to barcoded microarrays, mass-spectrometry and next generation sequencing, supplying all reagents, instruments, materials and support necessary. Its complete solutions guide diagnostic operators from sample extraction, quality control, molecular assay to bioinformatic analysis and report.The latest products launched include a liquid biopsy cfDNA extraction kit, a real-time PCR system with all reagent provided in a dry and stable format, micro-satellite instability assays and an end-to-end NGS solution that works on both Illumina and IonTorrent platforms.All Diatech products are developed under EN ISO 9001 and EN ISO 13485 and have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD). Private Equity / Jun 07, 2021
C.E.I. High Fidelity Spare Parts C.E.I. High Fidelity Spare Parts
CEI is a manufacturer and designer of spare parts for industrial vehicles. The initial product range consisting exclusively of gears for gearboxes and differentials has been widened through the years by introducing spare parts for steering and braking system, suspensions, and engine. Private Equity / Apr 01, 2020
Chilibeli Chilibeli
Chilibeli is a social commerce platform that connects manufacturers/farmers with agents directly through various messaging tools.The company empowers farmers and its network of agents to earn extra income with ease and flexibility by streamlining the end-to-end supply chain. It aims to help more local farmers, agents, and consumers benefitfrom the social economy.The company was founded in 2019 by Alex Feng, Damon Yue, and Matt Li. It is based in Setiabudi, Jakarta, $10M / Series A / Mar 20, 2020
Olimpia Splendid Olimpia Splendid
Olimpia Splendid is in air conditioning, heating, air treatment and hydronic systems thanks to their unique, innovative products. Private Equity / May 06, 2019
Italian Pharmaceutical Workshop Italian Pharmaceutical Workshop
Italian Pharmaceutical Workshop is a development and contract manufacturer of food supplements, medical devices, and cosmetics products. Their services include research, development, marketing consultancy, production, warehouse, logistics, and sales assistance services. They specialize in the production of various shapes and types of packaging,including bottles, stick packs, sachets, jars, tubes, airless capsules, and tablets. Private Equity / Apr 01, 2019
BIA BIA
BIA S.p.A., has been producing for more than 10 years high quality couscous in a wide range of categories. All BIA products are entirely manufactured in Italy. Characterized by advanced technological systems, BIA S.p.A. combines the progress and the consequent production performance with the history of a product that comes from the simplicity oftradition and processing of semolina.This is like a kind of bridge between past and present that allows you to create unique couscous dishes with pleasant taste, versatility and ease of preparation. BIA S.p.A., currently present in 50 countries worldwide, has as its primary objective the care of the product, of the consumer and of the environment. Private Equity / Jan 01, 2019
Millefili Millefili
Millefili, founded in 1981 in Carpi (Modena) by Francesco Galli, is specialised in the production and distribution of high quality yarns.Founded as a distributor of yarns for the knitwear industry and subsequently evolved into a manufacturing company, Millefili stands out from its main competitors thanks to its creativity and ability to capturefashion trends and to the high level of service. Such factors allowed the Company to grow and establish itself as a leader in its core business.The Company serves primary international brands in the fashion and luxury industries.It develops, produces and commercializes its yarns – often exclusive and designed ad hoc for the single customer – in Italy and in the main European and the US markets. Private Equity / Apr 01, 2018
Tricobiotos Tricobiotos
Tricobiotos is specialised in the production and distribution of professional haircare products, both under its own brands and as an exclusive dealer in Italy for primary international firms. Private Equity / Jun 01, 2017
See all 13 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Isle of Man
Haiti
Iran
Madagascar
Pakistan
Lesotho
Romania
Poland
Oman
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Marshall Islands
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Alto Partners SGR invest in?

Alto Partners SGR invests primarily in Manufacturing, Health Care and Pharmaceutical startups, most often at Private Equity and Series A stage. Most of the 13 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Alto Partners SGR?

Public channels for Alto Partners SGR include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Alto Partners SGR?

The team at Alto Partners SGR includes Mario Visioni (Partner), Raffaele de Courten (Founding Partner) and Stefano Scarpis (Founding Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Alto Partners SGR Alto Partners SGR Find emails